SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (706)4/9/2007 11:11:55 PM
From: JibacoaRead Replies (1) | Respond to of 802
 
I thought you were making a killing on DNDN since you were right in anticipating the FDA's panel decision.

I still have a few INGN shrs left & I think that if the FDA gives an OK to DNDN's Provenge there could be a good short squeeze on INGN's shorts.Today's move probably had already some short covering, since at last month count it would take about 24 days for them to cover at the average daily volume.<g>

RAGL

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News